speb/financial-data huggingface dataset:
Financial ratios for AVGO — annual report dated 2022-10-31
Total revenue: 33203000000
Gross profit: 22095000000
Operating income: 14282000000
Net income: 11495000000
Capital expenditures: 424000000
Operating cash flow: 16736000000
Depreciation & amortization: 4984000000
Net tangible assets: -28016000000
Owner earnings: 16055000000
Return on net tangible assets (%): -57.30653912050258
Capex to operating income (%): 2.9687718806889793
Buffett classification: The Great
Stock price: 44.41
P/E ratio: 18.380525149471943
Shares outstanding: 4757580198
Book value: 22709000000
P/B ratio: 9.303982411959135
Market cap (USD): 211284136593.18
Debt to equity: 1.7400590074419833
Current ratio: 2.6239364719228586
Quick ratio: 2.350964265456608
Effective tax rate (%): 7.5518738941611705
Interest coverage ratio: 8.222222222222221
COGS to revenue (%): 33.45480830045478
R&D to revenue (%): 14.814926362075717
SG&A to revenue (%): 4.162274493268681
Free cash flow (dilution-adjusted): 14779000000
Buyback yield (%): 4.001720212568443
Retained earnings: 1604000000
Inventory turnover: 5.770389610389611
Receivables turnover: 11.224814063556456
Capitalized R&D asset: 4919000000
ROCI (R&D-adjusted, %): 24.69392729249864
FCF margin (%): 44.511038159202485
Rule of 40 score: 44.511038159202485
Financial ratios for AVGO — annual report dated 2023-10-31
Total revenue: 35819000000
Gross profit: 24690000000
Operating income: 16451000000
Net income: 14082000000
Capital expenditures: 452000000
Operating cash flow: 18085000000
Depreciation & amortization: 3835000000
Net tangible assets: -23532000000
Owner earnings: 17465000000
Return on net tangible assets (%): -74.21808601053884
Capex to operating income (%): 2.747553340222479
Buffett classification: The Great
Stock price: 81.6
P/E ratio: 27.56842381457179
Shares outstanding: 4757580198
Book value: 23988000000
P/B ratio: 16.18386460550275
Market cap (USD): 388218544156.8
Debt to equity: 1.6353593463398366
Current ratio: 2.8152599594868333
Quick ratio: 2.5589466576637405
Effective tax rate (%): 6.723190037755845
Interest coverage ratio: 10.14241676942047
COGS to revenue (%): 31.07010245958849
R&D to revenue (%): 14.665401044138585
SG&A to revenue (%): 4.444568525084453
Free cash flow (dilution-adjusted): 15462000000
Buyback yield (%): 1.9795551025754345
Retained earnings: 2682000000
Inventory turnover: 5.863540569020021
Receivables turnover: 9.805365453052286
Capitalized R&D asset: 8548730000
ROCI (R&D-adjusted, %): 24.746165999569666
Rosenberg metric: 0.5275462492376499
FCF margin (%): 43.16703425556269
Revenue growth (%): 7.8788061319760265
Rule of 40 score: 51.04584038753872
Financial ratios for AVGO — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 167.18
Shares outstanding: 4757580198
Market cap (USD): 795372257501.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVGO — annual report dated 2024-10-31
Total revenue: 51574000000
Gross profit: 32509000000
Operating income: 14996000000
Net income: 5895000000
Capital expenditures: 548000000
Operating cash flow: 19962000000
Depreciation & amortization: 10010000000
Net tangible assets: -70778000000
Owner earnings: 15357000000
Return on net tangible assets (%): -21.697420102291673
Capex to operating income (%): 3.6543078154174444
Buffett classification: The Great
Stock price: 167.18
P/E ratio: 134.92319889764886
Shares outstanding: 4757580198
Book value: 67678000000
P/B ratio: 11.752301449535151
Market cap (USD): 795372257501.64
Debt to equity: 0.998345104760779
Current ratio: 1.1735641133137689
Quick ratio: 1.068155956159789
Effective tax rate (%): 37.79749899152884
Interest coverage ratio: 3.7935745003794588
COGS to revenue (%): 36.96630084926513
R&D to revenue (%): 18.051731492612557
SG&A to revenue (%): 9.615310039942607
Free cash flow (dilution-adjusted): 13673000000
Buyback yield (%): 1.5580126014106606
Retained earnings: 0
Inventory turnover: 10.832386363636363
Receivables turnover: 8.144977890082123
Capitalized R&D asset: 14452780000
ROCI (R&D-adjusted, %): 10.90080475748035
Rosenberg metric: 1.4884827717494764
FCF margin (%): 26.5114204831892
Revenue growth (%): 43.98503587481504
Rule of 40 score: 70.49645635800424
Financial ratios for AVGO — quarterly report dated 2025-01-31
Total revenue: 14916000000
Gross profit: 10145000000
Operating income: 6432000000
Net income: 5503000000
Capital expenditures: 100000000
Operating cash flow: 6113000000
Depreciation & amortization: 2174000000
Net tangible assets: -66665000000
Owner earnings: 7577000000
Return on net tangible assets (%): -11.365784144603614
Capex to operating income (%): 1.554726368159204
Buffett classification: The Great
Stock price: 218.48
P/E ratio: 47.22133934485917
Shares outstanding: 4757580198
Book value: 69789000000
P/B ratio: 14.893982169955722
Market cap (USD): 1039436121659.0399
Debt to equity: 0.9540042126982762
Current ratio: 1.0038259206121474
Quick ratio: 0.9125777140124343
Effective tax rate (%): -0.23679417122040072
Interest coverage ratio: 7.367697594501718
COGS to revenue (%): 31.98578707428265
R&D to revenue (%): 15.10458567980692
SG&A to revenue (%): 6.362295521587558
Free cash flow (dilution-adjusted): 4733000000
Buyback yield (%): 0.19587543260959106
Retained earnings: 2729000000
Inventory turnover: 2.500524109014675
Receivables turnover: 1.94294646346229
Capitalized R&D asset: 2253000000
ROCI (R&D-adjusted, %): 5.408279425498122
FCF margin (%): 31.731027085009384
Rule of 40 score: 31.731027085009384
Financial ratios for AVGO — quarterly report dated 2025-04-30
Total revenue: 15004000000
Gross profit: 10197000000
Operating income: 5915000000
Net income: 4965000000
Capital expenditures: 144000000
Operating cash flow: 6555000000
Depreciation & amortization: 2166000000
Net tangible assets: -64608000000
Owner earnings: 6987000000
Return on net tangible assets (%): -10.814450222882616
Capex to operating income (%): 2.4344885883347422
Buffett classification: The Great
Stock price: 190.62
P/E ratio: 45.664145888356494
Shares outstanding: 4757580198
Book value: 69586000000
P/B ratio: 13.032649345310263
Market cap (USD): 906889937342.76
Debt to equity: 0.966889891644871
Current ratio: 1.0769044035539157
Quick ratio: 0.9789775209982037
Effective tax rate (%): 2.359882005899705
Interest coverage ratio: 7.691807542262679
COGS to revenue (%): 32.038123167155426
R&D to revenue (%): 17.9485470541189
SG&A to revenue (%): 7.218075179952013
Free cash flow (dilution-adjusted): 4640000000
Buyback yield (%): 0.4648855198849293
Retained earnings: 2686000000
Inventory turnover: 2.383242439266237
Receivables turnover: 1.7055814482209843
Capitalized R&D asset: 4202510000
ROCI (R&D-adjusted, %): 4.694781522547015
Rosenberg metric: 0.0230803373280071
FCF margin (%): 30.925086643561716
Revenue growth (%): 0.5899705014749262
Rule of 40 score: 31.515057145036643
Financial ratios for AVGO — quarterly report dated 2025-07-31
Total revenue: 15952000000
Gross profit: 10703000000
Operating income: 6074000000
Net income: 4140000000
Capital expenditures: 142000000
Operating cash flow: 7166000000
Depreciation & amortization: 2202000000
Net tangible assets: -58868000000
Owner earnings: 6200000000
Return on net tangible assets (%): -10.532037779438744
Capex to operating income (%): 2.3378333882120512
Buffett classification: The Great
Stock price: 291.56
P/E ratio: 94.95619403949068
Shares outstanding: 4757580198
Book value: 73277000000
P/B ratio: 18.929815392672733
Market cap (USD): 1387120082528.8801
Debt to equity: 0.8765233292847687
Current ratio: 1.4965277777777777
Quick ratio: 1.3660201149425288
Effective tax rate (%): 21.665089877010406
Interest coverage ratio: 7.526641883519207
COGS to revenue (%): 32.90496489468405
R&D to revenue (%): 19.11985957873621
SG&A to revenue (%): 6.720160481444333
Free cash flow (dilution-adjusted): 4702000000
Buyback yield (%): 0.004181325087173369
Retained earnings: 4040000000
Inventory turnover: 2.407798165137615
Receivables turnover: 1.4976997465026758
Capitalized R&D asset: 5597800000
ROCI (R&D-adjusted, %): 4.1799663635241835
Rosenberg metric: 0.18789454140363906
FCF margin (%): 29.47592778335005
Revenue growth (%): 6.318315115969075
Rule of 40 score: 35.79424289931912
Financial ratios for AVGO — quarterly report dated 2025-10-31
Total revenue: 18015000000
Gross profit: 12249000000
Operating income: 7654000000
Net income: 8518000000
Capital expenditures: 237000000
Operating cash flow: 7703000000
Depreciation & amortization: 2233000000
Net tangible assets: -48782000000
Owner earnings: 10514000000
Return on net tangible assets (%): -21.553031856012463
Capex to operating income (%): 3.096420172458845
Buffett classification: The Great
Stock price: 367.57
P/E ratio: 75.61808152637118
Shares outstanding: 4757580198
Book value: 81292000000
P/B ratio: 21.511880054357867
Market cap (USD): 1748743753378.8599
Debt to equity: 0.8012596565467697
Current ratio: 1.7053581073782003
Quick ratio: 1.5827481905584964
Effective tax rate (%): -24.006405590333383
Interest coverage ratio: 10.057818659658345
COGS to revenue (%): 32.00666111573688
R&D to revenue (%): 16.547321676380793
SG&A to revenue (%): 6.144879267277268
Free cash flow (dilution-adjusted): 5271000000
Buyback yield (%): 0
Retained earnings: 9761000000
Inventory turnover: 2.540088105726872
Receivables turnover: 1.482716049382716
Capitalized R&D asset: 5913190000
ROCI (R&D-adjusted, %): 4.8753498538309925
Rosenberg metric: 0.5068852459016393
FCF margin (%): 29.258950874271438
Revenue growth (%): 12.932547642928785
Rule of 40 score: 42.19149851720022
Financial ratios for AVGO — annual report dated 2025-10-31
Total revenue: 63887000000
Gross profit: 43294000000
Operating income: 26075000000
Net income: 23126000000
Capital expenditures: 623000000
Operating cash flow: 27537000000
Depreciation & amortization: 8775000000
Net tangible assets: -48782000000
Owner earnings: 31278000000
Return on net tangible assets (%): -64.11791234471731
Capex to operating income (%): 2.389261744966443
Buffett classification: The Great
Stock price: 367.57
P/E ratio: 75.61808152637118
Shares outstanding: 4757580198
Book value: 81292000000
P/B ratio: 21.511880054357867
Market cap (USD): 1748743753378.8599
Debt to equity: 0.8012596565467697
Current ratio: 1.7053581073782003
Quick ratio: 1.5827481905584964
Effective tax rate (%): -1.74666725328875
Interest coverage ratio: 8.123052959501557
COGS to revenue (%): 32.23347472881807
R&D to revenue (%): 17.181899290935558
SG&A to revenue (%): 6.591325308748258
Free cash flow (dilution-adjusted): 19346000000
Buyback yield (%): 0.3608304525924993
Retained earnings: 9761000000
Inventory turnover: 9.071806167400881
Receivables turnover: 5.258189300411523
Capitalized R&D asset: 18948190000
ROCI (R&D-adjusted, %): 16.638081138901683
Rosenberg metric: 1.1584317937701396
FCF margin (%): 30.28159093399283
Revenue growth (%): 23.874432853763526
Rule of 40 score: 54.156023787756354
Financial ratios for AVGO — quarterly report dated 2026-01-31
Total revenue: 19311000000
Gross profit: 13157000000
Operating income: 8666000000
Net income: 7349000000
Capital expenditures: 250000000
Operating cash flow: 8260000000
Depreciation & amortization: 2153000000
Net tangible assets: -48231000000
Owner earnings: 9252000000
Return on net tangible assets (%): -19.182683336443365
Capex to operating income (%): 2.884837295176552
Buffett classification: The Great
Stock price: 330.08
P/E ratio: 62.885714870889
Shares outstanding: 4757580198
Book value: 79872000000
P/B ratio: 19.661233871141825
Market cap (USD): 1570382071755.8398
Debt to equity: 0.8270357572115384
Current ratio: 1.9017735334242838
Quick ratio: 1.726081024971825
Effective tax rate (%): 10.323367907260526
Interest coverage ratio: 10.818976279650437
COGS to revenue (%): 31.86784734089379
R&D to revenue (%): 15.353943348350683
SG&A to revenue (%): 5.276785251928953
Free cash flow (dilution-adjusted): 5834000000
Buyback yield (%): 0.4998783507011728
Retained earnings: 6520000000
Inventory turnover: 2.0776502363268063
Receivables turnover: 1.379751357530723
Capitalized R&D asset: 5968770000
ROCI (R&D-adjusted, %): 5.428704457719549
Rosenberg metric: 0.30459577323045955
FCF margin (%): 30.21076070633318
Revenue growth (%): 7.194004995836803
Rule of 40 score: 37.40476570216998
Financial ratios for BDM.AX — annual report dated 2021-06-30
Operating income: -6751718.2481203005
Net income: -6845665.924812029
Capital expenditures: 4272.451127819549
Depreciation & amortization: 432.72180451127815
Net tangible assets: 805201.4887218045
Owner earnings: -6849505.654135337
Return on net tangible assets (%): -850.6573509952647
Buffett classification: The Gruesome
Stock price: 0.21804511278195485
Shares outstanding: 1421701987
Book value: 805201.4887218045
P/B ratio: 384.9908059532252
Market cap (USD): 309995170.0977443
Debt to equity: 0
Current ratio: 5.041585270794001
Quick ratio: 5.041585270794001
Free cash flow (dilution-adjusted): -5721345.458646616
Buyback yield (%): 0.06502713975112666
Retained earnings: -14911514.488721803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -838.5128868599256
Rule of 40 score: 0
Financial ratios for BDM.AX — annual report dated 2022-06-30
Operating income: -7638362.75862069
Net income: -9350835.172413792
Capital expenditures: 1538438
Depreciation & amortization: 87361.63448275861
Net tangible assets: 2525203.5724137933
Owner earnings: -10801911.537931034
Return on net tangible assets (%): -427.763989245655
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 1421701987
Book value: 2525203.5724137947
P/B ratio: 54.359093878502925
Market cap (USD): 137267778.05517244
Debt to equity: 5.558119121720079
Current ratio: 16.40218943535075
Quick ratio: 11.023521928453626
Interest coverage ratio: -4.971553570350233
Free cash flow (dilution-adjusted): -13678209.310344828
Buyback yield (%): 0
Retained earnings: -21873639.12413793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -46.19194813041265
Rule of 40 score: 0
Financial ratios for BDM.AX — annual report dated 2023-06-30
Total revenue: 2273077.668874172
Gross profit: -407976.52980132453
Operating income: -7846054.688741722
Net income: -12268771.165562915
Capital expenditures: 718614.4768211921
Depreciation & amortization: 364891.7947019868
Net tangible assets: 72676347.03311259
Owner earnings: -12622493.84768212
Return on net tangible assets (%): -17.368090669074352
Buffett classification: The Gruesome
Stock price: 0.1986754966887417
Shares outstanding: 1421701987
Book value: 109847262.25165564
P/B ratio: 2.571364480286251
Market cap (USD): 282457348.410596
Debt to equity: 0.12741435606620694
Current ratio: 36.00752558249482
Quick ratio: 35.074467258607484
Interest coverage ratio: -3.86353369728065
COGS to revenue (%): 117.94820015997915
SG&A to revenue (%): 226.38626094967873
Free cash flow (dilution-adjusted): -8186374.78807947
Buyback yield (%): 0
Retained earnings: -32480062.377483442
Inventory turnover: 0.7723238307696345
Receivables turnover: 0.8595766963515433
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.9912576550020145
FCF margin (%): -360.14496557586097
Rule of 40 score: -360.14496557586097
Financial ratios for BPT.L — annual report dated 2021-12-31
Operating income: 95000000
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.057432432432432436
Shares outstanding: 875407092
Market cap (USD): 50276758.66216216
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPT.L — annual report dated 2022-12-31
Total revenue: 320120481.92771083
Gross profit: 202530120.48192772
Operating income: 92771084.3373494
Net income: 145301204.8192771
Capital expenditures: 27228915.662650604
Operating cash flow: 40843373.49397591
Depreciation & amortization: 22048192.77108434
Net tangible assets: 786867469.8795182
Owner earnings: 140120481.92771083
Return on net tangible assets (%): 17.807380186801407
Capex to operating income (%): 29.35064935064935
Buffett classification: The Good
Stock price: 0.02036144578313253
P/E ratio: 0.12267313312437811
Shares outstanding: 875407092
Book value: 930963855.4216869
P/B ratio: 0.019146343800698844
Market cap (USD): 17824554.04192771
Debt to equity: 0.9206677882748802
Current ratio: 4.836434108527132
Quick ratio: 4.836434108527132
Effective tax rate (%): 5.337519623233909
Interest coverage ratio: 16.382978723404257
COGS to revenue (%): 36.73315769665036
Free cash flow (dilution-adjusted): 13132530.120481929
Buyback yield (%): 0
Retained earnings: 570722891.5662651
Receivables turnover: 21.778688524590162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.033337691201464
FCF margin (%): 4.102371095220174
Rule of 40 score: 4.102371095220174
Financial ratios for BPT.L — annual report dated 2023-12-31
Total revenue: 373797468.3544304
Gross profit: 252658227.84810126
Operating income: 126455696.20253164
Net income: 89493670.88607594
Capital expenditures: 5063291.139240506
Operating cash flow: 120253164.55696201
Depreciation & amortization: 23670886.075949367
Net tangible assets: 765316455.6962025
Owner earnings: 108101265.82278481
Return on net tangible assets (%): 14.125041349652664
Capex to operating income (%): 4.004004004004004
Buffett classification: The Great
Stock price: 0.03265822784810127
P/E ratio: 0.3194554876039605
Shares outstanding: 875407092
Book value: 912911392.4050634
P/B ratio: 0.03131655986356073
Market cap (USD): 28589244.27037975
Debt to equity: 1.7706600110926232
Current ratio: 5.316849274503998
Quick ratio: 5.316849274503998
Effective tax rate (%): 17.790697674418606
Interest coverage ratio: 18.849056603773583
COGS to revenue (%): 32.40772096173383
SG&A to revenue (%): 0.6434134778191669
Free cash flow (dilution-adjusted): 105696202.53164557
Buyback yield (%): 266.5426582280114
Retained earnings: 530000000
Receivables turnover: 16.874285714285715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.897058823529411
FCF margin (%): 28.276329156789703
Revenue growth (%): 16.767745101308705
Rule of 40 score: 45.044074258098405
Financial ratios for BPT.L — annual report dated 2024-12-31
Total revenue: 485375000
Gross profit: 326750000
Operating income: 102625000
Net income: 86375000
Capital expenditures: 3625000
Operating cash flow: 13500000
Depreciation & amortization: 45250000
Net tangible assets: 255125000
Owner earnings: 128000000
Return on net tangible assets (%): 50.171484566389026
Capex to operating income (%): 3.5322777101096223
Buffett classification: The Great
Stock price: 0.042875
P/E ratio: 0.43453637128219974
Shares outstanding: 875407092
Book value: 1491375000
P/B ratio: 0.025166761592154894
Market cap (USD): 37533079.0695
Debt to equity: 1.9424189087251698
Current ratio: 5.672139181573144
Quick ratio: 5.672139181573144
Effective tax rate (%): 14.374225526641885
Interest coverage ratio: 3.890995260663507
COGS to revenue (%): 32.680916816894154
SG&A to revenue (%): 0.5923255215039918
Free cash flow (dilution-adjusted): -38375000
Buyback yield (%): 32.63787651771568
Retained earnings: 698375000
Receivables turnover: 15.16796875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.225716377043403
FCF margin (%): -7.906258047901107
Revenue growth (%): 29.84972908906197
Rule of 40 score: 21.943471041160862
Financial ratios for BPT.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 255125000
Buffett classification: The Gruesome
Stock price: 0.042875
Shares outstanding: 875407092
Book value: 1491375000
P/B ratio: 0.025166761592154894
Market cap (USD): 37533079.0695
Debt to equity: 1.9424189087251698
Current ratio: 5.672139181573144
Quick ratio: 5.672139181573144
Buyback yield (%): 0
Retained earnings: 698375000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPT.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 308630136.98630136
Buffett classification: The Gruesome
Stock price: 0.04123287671232877
Shares outstanding: 875407092
Book value: 1596712328.7671232
P/B ratio: 0.022606171473232673
Market cap (USD): 36095552.69753425
Debt to equity: 2.4167810569663692
Current ratio: 6.816029997656434
Quick ratio: 6.816029997656434
Buyback yield (%): 0
Retained earnings: 767671232.8767123
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — annual report dated 2021-10-31
Capital expenditures: 24623.577235772358
Buffett classification: The Gruesome
Stock price: 0.04878048780487805
Shares outstanding: 31285623
Market cap (USD): 1526127.9512195121
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — annual report dated 2022-10-31
Total revenue: 0
Operating income: -130658.82352941176
Net income: -112241.91176470587
Capital expenditures: 53558.82352941176
Operating cash flow: -94941.17647058822
Net tangible assets: 722466.1764705882
Owner earnings: -165800.73529411765
Return on net tangible assets (%): -22.949273017055553
Buffett classification: The Gruesome
Stock price: 0.05147058823529412
Shares outstanding: 31285623
Book value: 722466.1764705882
P/B ratio: 2.2288786265182376
Market cap (USD): 1610289.4191176472
Debt to equity: 0
Current ratio: 6.674399282129682
Quick ratio: 6.674399282129682
Free cash flow (dilution-adjusted): -148500
Buyback yield (%): 0
Retained earnings: -7335480.147058823
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.085112879292133
Rule of 40 score: 0
Financial ratios for BST.V — annual report dated 2023-10-31
Total revenue: 0
Operating income: -73421.73913043478
Net income: -67673.1884057971
Capital expenditures: 13715.942028985508
Operating cash flow: -86107.97101449277
Net tangible assets: 644322.463768116
Owner earnings: -81389.13043478261
Return on net tangible assets (%): -12.631738766145764
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 31285623
Book value: 644322.463768116
P/B ratio: 1.0555618923371926
Market cap (USD): 680122.2391304348
Debt to equity: 0
Current ratio: 9.333013245033113
Quick ratio: 9.333013245033113
Free cash flow (dilution-adjusted): -99823.91304347827
Buyback yield (%): 0
Retained earnings: -7296842.028985508
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.395185370544274
Rule of 40 score: 0
Financial ratios for BST.V — annual report dated 2024-10-31
Total revenue: 0
Operating income: -117196.40287769785
Net income: -631093.5251798561
Capital expenditures: 54346.04316546763
Operating cash flow: -111807.91366906476
Net tangible assets: 8593.525179856115
Owner earnings: -685439.5683453238
Return on net tangible assets (%): -7976.23273336124
Buffett classification: The Gruesome
Stock price: 0.014388489208633094
Shares outstanding: 31285623
Book value: 8593.525179856122
P/B ratio: 52.38279280033483
Market cap (USD): 450152.84892086335
Debt to equity: 0
Current ratio: 1.1488827893811382
Quick ratio: 1.1488827893811382
Free cash flow (dilution-adjusted): -166153.95683453238
Buyback yield (%): 0
Retained earnings: -7875440.287769785
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1363.7756383424016
Rule of 40 score: 0
Financial ratios for BST.V — quarterly report dated 2024-10-31
Total revenue: 0
Operating income: -32117.26618705036
Net income: -549714.3884892086
Capital expenditures: 36058.9928057554
Operating cash flow: 11664.74820143885
Net tangible assets: 8593.525179856115
Owner earnings: -585773.381294964
Return on net tangible assets (%): -6816.450397655924
Buffett classification: The Gruesome
Stock price: 0.014388489208633094
Shares outstanding: 31285623
Book value: 8593.525179856122
P/B ratio: 52.38279280033483
Market cap (USD): 450152.84892086335
Debt to equity: 0
Current ratio: 1.1488827893811382
Quick ratio: 1.1488827893811382
Free cash flow (dilution-adjusted): -24394.244604316547
Buyback yield (%): 0
Retained earnings: -7875440.287769785
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -373.73796567601477
Rule of 40 score: 0
Financial ratios for BST.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -12766.896551724138
Net income: -12655.862068965518
Capital expenditures: 0
Operating cash flow: -19219.310344827587
Net tangible assets: -4417.931034482759
Owner earnings: -12655.862068965518
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 31285623
Book value: -4417.931034482761
Market cap (USD): 647288.7517241379
Debt to equity: 0
Current ratio: 0.6815009213244736
Quick ratio: 0.6815009213244736
Free cash flow (dilution-adjusted): -19219.310344827587
Buyback yield (%): 0
Retained earnings: -7562215.862068966
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -15010.869565217392
Net income: -9915.217391304348
Capital expenditures: 0
Operating cash flow: -12086.956521739132
Net tangible assets: -14557.246376811596
Owner earnings: -9915.217391304348
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 31285623
Book value: -14557.246376811596
Market cap (USD): 680122.2391304348
Debt to equity: 0
Current ratio: 0.3593023849650171
Quick ratio: 0.3593023849650171
Free cash flow (dilution-adjusted): -12086.956521739132
Buyback yield (%): 0
Retained earnings: -7955721.7391304355
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -69606.42857142858
Net income: -69607.14285714286
Capital expenditures: 0
Operating cash flow: -33785.71428571429
Net tangible assets: -38550.71428571429
Owner earnings: -69607.14285714286
Buffett classification: The Gruesome
Stock price: 0.028571428571428574
Shares outstanding: 31285623
Book value: -38550.71428571429
Market cap (USD): 893874.9428571429
Debt to equity: 0
Current ratio: 0.3485139222025237
Quick ratio: 0.3485139222025237
Free cash flow (dilution-adjusted): -33785.71428571429
Buyback yield (%): 0
Retained earnings: -7930270.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — annual report dated 2025-10-31
Total revenue: 0
Operating income: -116220.00000000001
Net income: -111083.57142857143
Capital expenditures: 0
Operating cash flow: -78828.57142857143
Net tangible assets: -38550.71428571429
Owner earnings: -111083.57142857143
Buffett classification: The Gruesome
Stock price: 0.028571428571428574
Shares outstanding: 31285623
Book value: -38550.71428571429
Market cap (USD): 893874.9428571429
Debt to equity: 0
Current ratio: 0.3485139222025237
Quick ratio: 0.3485139222025237
Free cash flow (dilution-adjusted): -78828.57142857143
Buyback yield (%): 0
Retained earnings: -7930270.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BST.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -17655.555555555555
Net income: -17655.555555555555
Capital expenditures: 0
Operating cash flow: -6907.407407407407
Net tangible assets: -57634.07407407407
Owner earnings: -17655.555555555555
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 31285623
Book value: -57634.074074074066
Market cap (USD): 926981.4222222222
Debt to equity: -0.4498367735136108
Current ratio: 0.22115636252064289
Quick ratio: 0.22115636252064289
Free cash flow (dilution-adjusted): -6907.407407407407
Buyback yield (%): 0
Retained earnings: -8241639.999999999
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYSI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 41119820
Market cap (USD): 186272784.60000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYSI — annual report dated 2022-12-31
Total revenue: 1351000
Operating income: -37239000
Net income: -33279000
Capital expenditures: 683000
Operating cash flow: -28151000
Depreciation & amortization: 232000
Net tangible assets: -5979000
Owner earnings: -33730000
Buffett classification: The Gruesome
Stock price: 1.88
Shares outstanding: 41119820
Book value: -3007000
Market cap (USD): 77305261.6
Debt to equity: -1.6498170934486198
Current ratio: 5.239798694232862
Quick ratio: 5.239798694232862
Interest coverage ratio: -2190.529411764706
COGS to revenue (%): 0
R&D to revenue (%): 1893.560325684678
SG&A to revenue (%): 962.8423390081421
Free cash flow (dilution-adjusted): -29851000
Buyback yield (%): 0
Retained earnings: -375276000
Capitalized R&D asset: 25582000
ROCI (R&D-adjusted, %): -31.316845611204208
FCF margin (%): -2209.5484826054776
Rule of 40 score: -2209.5484826054776
Financial ratios for BYSI — annual report dated 2023-12-31
Total revenue: 0
Operating income: -15081000
Net income: -21026000
Capital expenditures: 100000
Operating cash flow: -16474000
Depreciation & amortization: 302000
Net tangible assets: -26805000
Owner earnings: -20824000
Buffett classification: The Gruesome
Stock price: 0.9
Shares outstanding: 41119820
Book value: -23461000
Market cap (USD): 37007838
Debt to equity: -0.03610246792549337
Current ratio: 2.3145262628801206
Quick ratio: 2.3145262628801206
Free cash flow (dilution-adjusted): -17344000
Buyback yield (%): 0
Retained earnings: -396302000
Capitalized R&D asset: 24411940
ROCI (R&D-adjusted, %): -45.466435493176846
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for BYSI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.29
Shares outstanding: 41119820
Market cap (USD): 94164387.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYSI — annual report dated 2024-12-31
Total revenue: 0
Operating income: -8754000
Net income: -11123000
Capital expenditures: 224000
Operating cash flow: -16443000
Depreciation & amortization: 285000
Net tangible assets: -32900000
Owner earnings: -11062000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 41119820
Book value: -14285000
Market cap (USD): 67025306.599999994
Debt to equity: -0.041232061603080156
Current ratio: 2.5955495004541325
Quick ratio: 2.5955495004541325
Free cash flow (dilution-adjusted): -18922000
Buyback yield (%): 0
Retained earnings: -407425000
Capitalized R&D asset: 15958300
ROCI (R&D-adjusted, %): -45.698315390368776
Rule of 40 score: 0
Financial ratios for BYSI — quarterly report dated 2024-12-31
Capital expenditures: 27000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 41119820
Market cap (USD): 67025306.599999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYSI — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2610000
Net income: 4477000
Capital expenditures: 50000
Operating cash flow: -4198000
Depreciation & amortization: 80000
Net tangible assets: -28309000
Owner earnings: 4507000
Return on net tangible assets (%): -15.920731922710093
Buffett classification: The Gruesome
Stock price: 1.43
P/E ratio: 3.28352371007371
Shares outstanding: 41119820
Book value: -12667000
Market cap (USD): 58801342.599999994
Debt to equity: -0.043183074129628164
Current ratio: 2.4892222660876433
Quick ratio: 2.4892222660876433
Free cash flow (dilution-adjusted): -4492000
Buyback yield (%): 0
Retained earnings: -402948000
Capitalized R&D asset: 874000
ROCI (R&D-adjusted, %): -8.009059903343472
Rule of 40 score: 0
Financial ratios for BYSI — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1949000
Net income: -1806000
Capital expenditures: 0
Operating cash flow: -5874000
Depreciation & amortization: 82000
Net tangible assets: -30216000
Owner earnings: -1724000
Buffett classification: The Gruesome
Stock price: 2.35
P/E ratio: 36.178052040434295
Shares outstanding: 41119820
Book value: -17545000
Market cap (USD): 96631577
Debt to equity: -0.02718723282986606
Current ratio: 2.191901108269395
Quick ratio: 2.191901108269395
Free cash flow (dilution-adjusted): -6019000
Buyback yield (%): 0
Retained earnings: -404754000
Capitalized R&D asset: 1587580
ROCI (R&D-adjusted, %): -7.522917226858458
Rule of 40 score: 0
Financial ratios for BYSI — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1790000
Net income: -1540000
Capital expenditures: 0
Operating cash flow: -4193000
Depreciation & amortization: 81000
Net tangible assets: -31775000
Owner earnings: -1459000
Buffett classification: The Gruesome
Stock price: 1.81
P/E ratio: 65.80625481874448
Shares outstanding: 41119820
Book value: -19810000
Market cap (USD): 74426874.2
Debt to equity: -0.02049469964664311
Current ratio: 1.8936467302769373
Quick ratio: 1.8936467302769373
Free cash flow (dilution-adjusted): -4359000
Buyback yield (%): 0
Retained earnings: -406294000
Capitalized R&D asset: 1998760
ROCI (R&D-adjusted, %): -9.265753573984746
Rule of 40 score: 0
Financial ratios for BYSI — annual report dated 2025-12-31
Total revenue: 0
Operating income: -8945000
Net income: -1006000
Capital expenditures: 50000
Operating cash flow: -19769000
Depreciation & amortization: 87000
Net tangible assets: -32161000
Owner earnings: -969000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 41119820
Book value: -23990000
Market cap (USD): 67025306.599999994
Debt to equity: -0.013338891204668612
Current ratio: 1.53815556865056
Quick ratio: 1.53815556865056
Free cash flow (dilution-adjusted): -20541000
Buyback yield (%): 0
Retained earnings: -408431000
Capitalized R&D asset: 8559240
ROCI (R&D-adjusted, %): -44.58258272041247
Rule of 40 score: 0
Financial ratios for BYSI — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2596000
Net income: -2137000
Capital expenditures: 0
Operating cash flow: -5504000
Depreciation & amortization: -156000
Net tangible assets: -32161000
Owner earnings: -2293000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 41119820
Book value: -23990000
Market cap (USD): 67025306.599999994
Debt to equity: -0.013338891204668612
Current ratio: 1.53815556865056
Quick ratio: 1.53815556865056
Free cash flow (dilution-adjusted): -5671000
Buyback yield (%): 0
Retained earnings: -408431000
Capitalized R&D asset: 2499790
ROCI (R&D-adjusted, %): -15.44299497625889
Rule of 40 score: 0
Financial ratios for CETY — annual report dated 2023-12-31
Total revenue: 6693844
Gross profit: 460835
Operating income: -2925984
Net income: -5531762
Capital expenditures: 4621
Operating cash flow: -4783077
Depreciation & amortization: 26859
Net tangible assets: 2449158
Owner earnings: -5509524
Return on net tangible assets (%): -224.9558419669127
Buffett classification: The Gruesome
Stock price: 22.5
Shares outstanding: 12166106
Book value: 5869198
P/B ratio: 46.639657581836566
Market cap (USD): 273737385
Debt to equity: 0.4782723295414467
Current ratio: 1.1128780926756732
Quick ratio: 0.976402761482678
Interest coverage ratio: -1.3687859887193827
COGS to revenue (%): 93.11554018886606
SG&A to revenue (%): 46.505460838346394
Free cash flow (dilution-adjusted): -4935888
Buyback yield (%): 0
Retained earnings: -22984163
Inventory turnover: 9.353072344026902
Receivables turnover: 3.7291900883906615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.39871496243042
FCF margin (%): -73.73772080735674
Revenue growth (%): 151.3447671458374
Rule of 40 score: 77.60704633848067
Financial ratios for CETY — quarterly report dated 2024-09-30
Total revenue: 235183
Gross profit: 212541
Operating income: -759348
Net income: -1299391
Capital expenditures: 0
Operating cash flow: -1176574
Depreciation & amortization: 3349
Net tangible assets: 929526
Owner earnings: -1296042
Return on net tangible assets (%): -139.4304193750363
Buffett classification: The Gruesome
Stock price: 15
Shares outstanding: 12166106
Book value: 3583444
P/B ratio: 50.926312787363216
Market cap (USD): 182491590
Debt to equity: 1.0672930845298545
Current ratio: 0.8616492590669901
Quick ratio: 0.7250778734535719
Interest coverage ratio: -1.5848144592394706
COGS to revenue (%): 9.627396538015077
SG&A to revenue (%): 388.7100683297688
Free cash flow (dilution-adjusted): -1176574
Buyback yield (%): 0
Retained earnings: -26643673
Inventory turnover: 0.02946435310376418
Receivables turnover: 0.10023671554412183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.970470924064408
FCF margin (%): -500.2802073279106
Rule of 40 score: -500.2802073279106
Financial ratios for CETY — annual report dated 2024-12-31
Total revenue: 2424659
Gross profit: 846555
Operating income: -3330431
Net income: -4550296
Capital expenditures: 0
Operating cash flow: -3560951
Depreciation & amortization: 10423
Net tangible assets: -756772
Owner earnings: -4539873
Buffett classification: The Gruesome
Stock price: 9.21
Shares outstanding: 12166106
Book value: 1897145
P/B ratio: 59.06234697927676
Market cap (USD): 112049836.26
Debt to equity: 2.2866897364197256
Current ratio: 0.4776267687275645
Quick ratio: 0.402982046175217
Interest coverage ratio: -2.7775765986512564
COGS to revenue (%): 65.08560585220438
SG&A to revenue (%): 164.23765156254962
Free cash flow (dilution-adjusted): -3623201
Buyback yield (%): 0
Retained earnings: -28480730
Inventory turnover: 3.175240390903073
Receivables turnover: 1.055124404695594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -164.38260356244544
FCF margin (%): -149.4313633381024
Revenue growth (%): -63.77777850813374
Rule of 40 score: -213.20914184623612
Financial ratios for CETY — quarterly report dated 2024-12-31
Total revenue: 480326
Gross profit: 204980
Operating income: -560975
Net income: -865650
Capital expenditures: 0
Operating cash flow: -772343
Depreciation & amortization: 380
Net tangible assets: -756772
Owner earnings: -865270
Buffett classification: The Gruesome
Stock price: 9.21
Shares outstanding: 12166106
Book value: 1897145
P/B ratio: 59.06234697927676
Market cap (USD): 112049836.26
Debt to equity: 2.2866897364197256
Current ratio: 0.4776267687275645
Quick ratio: 0.402982046175217
Interest coverage ratio: -1.8885503635873957
COGS to revenue (%): 57.32481689519201
SG&A to revenue (%): 149.07437865116609
Free cash flow (dilution-adjusted): -772343
Buyback yield (%): 0
Retained earnings: -28480730
Inventory turnover: 0.5540127524381141
Receivables turnover: 0.20902060240628306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.68846765882339
FCF margin (%): -160.79558466541474
Revenue growth (%): 104.23499997873995
Rule of 40 score: -56.56058468667479
Financial ratios for CETY — quarterly report dated 2025-03-31
Total revenue: 791940
Gross profit: 728553
Operating income: -96103
Net income: -331231
Capital expenditures: 0
Operating cash flow: -776047
Depreciation & amortization: 3344
Net tangible assets: 300211
Owner earnings: -327887
Return on net tangible assets (%): -109.21884940924882
Buffett classification: The Gruesome
Stock price: 7.35
Shares outstanding: 12166106
Book value: 2951159
P/B ratio: 30.300258000331397
Market cap (USD): 89420879.1
Debt to equity: 1.659188135915415
Current ratio: 0.5294961549671579
Quick ratio: 0.45804895100238086
Interest coverage ratio: -0.2828047707469521
COGS to revenue (%): 8.004015455716342
SG&A to revenue (%): 99.66790413415157
Free cash flow (dilution-adjusted): -788047
Buyback yield (%): 0
Retained earnings: -27731745
Inventory turnover: 0.1257074975904427
Receivables turnover: 0.26858115326361
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.169648054718093
FCF margin (%): -99.50842235522893
Revenue growth (%): 64.87552204128029
Rule of 40 score: -34.63290031394864
Financial ratios for CETY — quarterly report dated 2025-06-30
Total revenue: 236275
Gross profit: 223657
Operating income: -718375
Net income: -1039745
Capital expenditures: 0
Operating cash flow: -764479
Depreciation & amortization: 3346
Net tangible assets: 5107709
Owner earnings: -1036399
Return on net tangible assets (%): -20.290877965052434
Buffett classification: The Gruesome
Stock price: 3.75
Shares outstanding: 12166106
Book value: 7755688
P/B ratio: 5.882508102440428
Market cap (USD): 45622897.5
Debt to equity: 0.5476645012022144
Current ratio: 1.3259650378598409
Quick ratio: 1.2563053739701375
Interest coverage ratio: -1.3880381878360806
COGS to revenue (%): 5.3403872606073435
SG&A to revenue (%): 377.4004867209819
Free cash flow (dilution-adjusted): -829016
Buyback yield (%): 0
Retained earnings: -28820537
Inventory turnover: 0.026035874124864074
Receivables turnover: 0.06894061522076898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.176636471961231
FCF margin (%): -350.86911437943075
Revenue growth (%): -70.16503775538551
Rule of 40 score: -421.0341521348163
Financial ratios for CETY — quarterly report dated 2025-09-30
Total revenue: 773554
Gross profit: 183105
Operating income: -1334802
Net income: -1996680
Capital expenditures: 0
Operating cash flow: -4590699
Depreciation & amortization: 3560
Net tangible assets: 4450123
Owner earnings: -1993120
Return on net tangible assets (%): -44.78797552337318
Buffett classification: The Gruesome
Stock price: 4.28
Shares outstanding: 12166106
Book value: 7095133
P/B ratio: 7.33896513004055
Market cap (USD): 52070933.68
Debt to equity: 0.522082108961171
Current ratio: 1.20337643462437
Quick ratio: 1.138868636153435
Interest coverage ratio: -0.8684593198206609
COGS to revenue (%): 76.32938359830082
SG&A to revenue (%): 189.6910881463996
Free cash flow (dilution-adjusted): -4668673
Buyback yield (%): 0
Retained earnings: -30922858
Inventory turnover: 1.2215891340553848
Receivables turnover: 0.22453667689178175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.26974246107352
FCF margin (%): -603.5354997841133
Revenue growth (%): 227.39561951116283
Rule of 40 score: -376.13988027295045
Financial ratios for CHCT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.04
Shares outstanding: 28571793
Market cap (USD): 944012040.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHCT — annual report dated 2022-12-31
Total revenue: 97679000
Gross profit: 81043000
Operating income: 33867000
Net income: 22019000
Capital expenditures: 10376000
Operating cash flow: 60280000
Depreciation & amortization: 33192000
Net tangible assets: 494415000
Owner earnings: 44835000
Return on net tangible assets (%): 9.068292830921392
Capex to operating income (%): 30.637493725455457
Buffett classification: The Good
Stock price: 26.2
P/E ratio: 33.997046941277986
Shares outstanding: 28571793
Book value: 496814000
P/B ratio: 1.5067630473376352
Market cap (USD): 748580976.6
Debt to equity: 0.7187035792067051
Current ratio: 4.392383453709783
Quick ratio: 4.392383453709783
Effective tax rate (%): 0.185856754306437
Interest coverage ratio: 2.852438305398804
COGS to revenue (%): 17.031296389193173
SG&A to revenue (%): 15.189549442561862
Free cash flow (dilution-adjusted): 40489000
Buyback yield (%): 0
Retained earnings: 81142000
Receivables turnover: 1.813976377952756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9325588281399684
FCF margin (%): 41.451079556506514
Rule of 40 score: 41.451079556506514
Financial ratios for CHCT — annual report dated 2023-12-31
Total revenue: 112845000
Gross profit: 92132000
Operating income: 25101000
Net income: 7714000
Capital expenditures: 18981000
Operating cash flow: 61383000
Depreciation & amortization: 40439000
Net tangible assets: 510611000
Owner earnings: 29172000
Return on net tangible assets (%): 5.713155415766601
Capex to operating income (%): 75.61850125493008
Buffett classification: The Gruesome
Stock price: 20.57
P/E ratio: 76.18897874124968
Shares outstanding: 28571793
Book value: 513256000
P/B ratio: 1.1450850686791778
Market cap (USD): 587721782.01
Debt to equity: 0.7935766946708854
Current ratio: 1.0418483904465212
Quick ratio: 1.0418483904465212
Effective tax rate (%): 3.815461346633416
Interest coverage ratio: 1.410802607913669
COGS to revenue (%): 18.355266072931897
SG&A to revenue (%): 24.226150914971864
Free cash flow (dilution-adjusted): 22437000
Buyback yield (%): 0
Retained earnings: 88856000
Receivables turnover: 1.9822059056017145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.858877314630263
FCF margin (%): 19.883025388807656
Revenue growth (%): 15.52636697754891
Rule of 40 score: 35.40939236635657
Financial ratios for CHCT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.88
Shares outstanding: 28571793
Market cap (USD): 425148279.84000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHCT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.15
Shares outstanding: 28571793
Market cap (USD): 461434456.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHCT — annual report dated 2024-12-31
Total revenue: 115786000
Gross profit: 92952000
Operating income: 20116000
Net income: -3181000
Capital expenditures: 24644000
Operating cash flow: 58881000
Depreciation & amortization: 43705000
Net tangible assets: 474033000
Owner earnings: 15880000
Capex to operating income (%): 122.50944521773712
Buffett classification: The Gruesome
Stock price: 16.15
Shares outstanding: 28571793
Book value: 475965000
P/B ratio: 0.9694714043049382
Market cap (USD): 461434456.95
Debt to equity: 1.0294454424169845
Current ratio: 0.2496123165215449
Quick ratio: 0.2496123165215449
Interest coverage ratio: 0.84856154560027
COGS to revenue (%): 19.720864353203325
SG&A to revenue (%): 16.459675608450073
Free cash flow (dilution-adjusted): 24250000
Buyback yield (%): 0
Retained earnings: 85675000
Receivables turnover: 2.555813080811425
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.647643365755426
FCF margin (%): 20.943810132485794
Revenue growth (%): 2.6062297842172892
Rule of 40 score: 23.550039916703085
Financial ratios for CHCT — quarterly report dated 2025-03-31
Total revenue: 30078000
Gross profit: 23983000
Operating income: 7940000
Net income: 1591000
Capital expenditures: 4682000
Operating cash flow: 14409000
Depreciation & amortization: 11288000
Net tangible assets: 459552000
Owner earnings: 8197000
Return on net tangible assets (%): 1.7836936842838242
Capex to operating income (%): 58.967254408060455
Buffett classification: The Good
Stock price: 15.66
P/E ratio: 70.30708334066624
Shares outstanding: 28571793
Book value: 461321000
P/B ratio: 0.9698979200600015
Market cap (USD): 447434278.38
Debt to equity: 1.0839177058924263
Current ratio: 0.2655546984133603
Quick ratio: 0.2655546984133603
Interest coverage ratio: 1.25
COGS to revenue (%): 20.263980317840282
SG&A to revenue (%): 16.955914621982846
Free cash flow (dilution-adjusted): 7017000
Buyback yield (%): 0
Retained earnings: 87266000
Receivables turnover: 0.565992999887095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0653442443905063
FCF margin (%): 23.329343706363456
Rule of 40 score: 23.329343706363456
Financial ratios for CHCT — quarterly report dated 2025-06-30
Total revenue: 29085000
Gross profit: 23500000
Operating income: -710000
Net income: -12557000
Capital expenditures: 4229000
Operating cash flow: 13799000
Depreciation & amortization: 11078000
Net tangible assets: 436195000
Owner earnings: -5708000
Return on net tangible assets (%): -1.3085890484760256
Buffett classification: The Gruesome
Stock price: 14.75
Shares outstanding: 28571793
Book value: 437820000
P/B ratio: 0.9625735387830615
Market cap (USD): 421433946.75
Debt to equity: 1.1513567219405234
Current ratio: 0.1966129143829067
Quick ratio: 0.1966129143829067
Interest coverage ratio: -0.10770631067961164
COGS to revenue (%): 19.202337974901152
SG&A to revenue (%): 16.01856627127385
Free cash flow (dilution-adjusted): 2448000
Buyback yield (%): 0
Retained earnings: 74709000
Receivables turnover: 0.8069975860825171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09853789198304037
FCF margin (%): 8.416709644146467
Revenue growth (%): -3.3014163175743065
Rule of 40 score: 5.115293326572161